Tags

Type your tag names separated by a space and hit enter

[Considerations on vaccines and immunization against COVID-19 for epidemic control in China].
Zhonghua Yu Fang Yi Xue Za Zhi. 2021 Dec 06; 55(12):1371-1376.ZY

Abstract

The Delta variant of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has caused a new global wave of the Coronavirus Disease 2019 (COVID-19) pandemic. COVID-19 vaccines currently available in China show high effectiveness against severe illness and death. However, transmission of the virus is not fully stopped by vaccination alone, therefore, integrated vaccination and non-pharmacological interventions is necessary to prevent and control the epidemic in the near future. Further expanded vaccine coverage of primary doses as well as booster shots in China's domestic population are needed to reduce severe illness and death. In order to provide evidence necessary for adjusting and optimizing immunization strategies and pandemic control measures, it is essential to conduct research on vaccine effectiveness against emerging variants, persistence of vaccine-induced protection, surveillance of adverse event following immunization with large-scale vaccine use, and modelling studies on strategic combinations of vaccination and non-pharmacological interventions.

Authors+Show Affiliations

National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing 100050, China.National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing 100050, China.National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing 100050, China.National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing 100050, China.National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing 100050, China.

Pub Type(s)

Journal Article

Language

chi

PubMed ID

34963231

Citation

Zhang, Q, et al. "[Considerations On Vaccines and Immunization Against COVID-19 for Epidemic Control in China]." Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine], vol. 55, no. 12, 2021, pp. 1371-1376.
Zhang Q, Wang FZ, Ma C, et al. [Considerations on vaccines and immunization against COVID-19 for epidemic control in China]. Zhonghua Yu Fang Yi Xue Za Zhi. 2021;55(12):1371-1376.
Zhang, Q., Wang, F. Z., Ma, C., An, Z. J., & Yin, Z. D. (2021). [Considerations on vaccines and immunization against COVID-19 for epidemic control in China]. Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine], 55(12), 1371-1376. https://doi.org/10.3760/cma.j.cn112150-20211015-00951
Zhang Q, et al. [Considerations On Vaccines and Immunization Against COVID-19 for Epidemic Control in China]. Zhonghua Yu Fang Yi Xue Za Zhi. 2021 Dec 6;55(12):1371-1376. PubMed PMID: 34963231.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Considerations on vaccines and immunization against COVID-19 for epidemic control in China]. AU - Zhang,Q, AU - Wang,F Z, AU - Ma,C, AU - An,Z J, AU - Yin,Z D, PY - 2021/12/28/entrez PY - 2021/12/29/pubmed PY - 2021/12/31/medline SP - 1371 EP - 1376 JF - Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] JO - Zhonghua Yu Fang Yi Xue Za Zhi VL - 55 IS - 12 N2 - The Delta variant of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has caused a new global wave of the Coronavirus Disease 2019 (COVID-19) pandemic. COVID-19 vaccines currently available in China show high effectiveness against severe illness and death. However, transmission of the virus is not fully stopped by vaccination alone, therefore, integrated vaccination and non-pharmacological interventions is necessary to prevent and control the epidemic in the near future. Further expanded vaccine coverage of primary doses as well as booster shots in China's domestic population are needed to reduce severe illness and death. In order to provide evidence necessary for adjusting and optimizing immunization strategies and pandemic control measures, it is essential to conduct research on vaccine effectiveness against emerging variants, persistence of vaccine-induced protection, surveillance of adverse event following immunization with large-scale vaccine use, and modelling studies on strategic combinations of vaccination and non-pharmacological interventions. SN - 0253-9624 UR - https://www.unboundmedicine.com/medline/citation/34963231/[Considerations_on_vaccines_and_immunization_against_COVID_19_for_epidemic_control_in_China]_ L2 - https://medlineplus.gov/covid19coronavirusdisease2019.html DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.